Donna Ucci

Corporate Officer/Principal at CORMEDIX INC.

Health Technology

Profile

Donna Ucci is currently the Senior Vice President & Head-Global Quality at CorMedix, Inc. She started this job in 2022.
Prior to this, she worked as the Vice President-Global Quality Management at Amneal Intermediate, Inc.

Donna Ucci active positions

Companies	Position	Start
CORMEDIX INC.	Corporate Officer/Principal	2022-05-11

All active positions of Donna Ucci

Former positions of Donna Ucci

Companies	Position	End
Amneal Intermediate, Inc. Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.	Corporate Officer/Principal	-

See the detail of Donna Ucci's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Donna Ucci's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CORMEDIX INC.	Health Technology

Private companies	1
Amneal Intermediate, Inc. Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.	Health Technology